# The Effect of Hydrocodone Bitartrate (HYD) Extended-Release Tablets on QT /QTc Intervals in Healthy Adult Subjects

> **NCT02243241** · PHASE1 · COMPLETED · sponsor: **Purdue Pharma LP** · enrollment: 208 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** HYD
- **DRUG:** Moxifloxacin
- **DRUG:** Placebo for HYD
- **DRUG:** Placebo for moxifloxacin

## Key facts

- **NCT ID:** NCT02243241
- **Lead sponsor:** Purdue Pharma LP
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-11
- **Primary completion:** 2013-05
- **Final completion:** 2013-05
- **Target enrollment:** 208 (ACTUAL)
- **Last updated:** 2014-09-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02243241

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02243241, "The Effect of Hydrocodone Bitartrate (HYD) Extended-Release Tablets on QT /QTc Intervals in Healthy Adult Subjects". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02243241. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*